A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
-1.47%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$324M
AUM Growth
+$324M
Cap. Flow
+$56.7M
Cap. Flow %
17.53%
Top 10 Hldgs %
90.01%
Holding
19
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

1
VERA icon
Vera Therapeutics
VERA
$38.5M
2
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$18.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 93.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$93.6M 28.94%
4,168,718
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$864M
$40.7M 12.59%
1,203,135
– –
VERA icon
3
Vera Therapeutics
VERA
$1.38B
$38.5M 11.91%
+2,960,231
New +$38.5M
SIEN
4
DELISTED
Sientra, Inc.
SIEN
$19M 5.88%
2,390,843
– –
OKUR
5
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$18.2M 5.62%
+1,962,221
New +$18.2M
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$16.8M 5.2%
871,125
– –
ACET icon
7
Adicet Bio
ACET
$59.9M
$16.6M 5.12%
1,615,385
– –
VRNA
8
Verona Pharma
VRNA
$9.16B
$16M 4.95%
2,457,499
– –
SLNO icon
9
Soleno Therapeutics
SLNO
$3.6B
$11.6M 3.6%
10,302,602
– –
XCUR icon
10
Exicure
XCUR
$35.4M
$10.4M 3.21%
6,977,000
– –
NCNA
11
NuCana
NCNA
$6.09M
$9.2M 2.84%
3,333,333
– –
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$7.09M 2.19%
1,041,131
– –
SYRE icon
13
Spyre Therapeutics
SYRE
$996M
$1.67M 0.52%
240,500
– –
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
$1.56M 0.48%
200,000
– –
XFOR icon
15
X4 Pharmaceuticals
XFOR
$84.2M
$1.49M 0.46%
229,885
– –
CBAY
16
DELISTED
Cymabay Therapeutics
CBAY
$571K 0.18%
131,036
– –
OBSV
17
DELISTED
ObsEva SA Ordinary Shares
OBSV
$266K 0.08%
87,999
– –
OCGN icon
18
Ocugen
OCGN
$319M
$57K 0.02%
7,111
– –